Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 3

Research Article

A Randomized Double-Blind Placebo-Controlled Trial to Evaluate Prophylactic Effect of Traditional Chinese Medicine Supplementing Qi and Hemostasis Formula on Gastrointestinal Bleeding after Percutaneous Coronary Intervention in Patients at High Risks

Table 3

Admitting diagnosis and operation.

Treatment (N=59)Control (N=58)StatisticP value

0.01(X2)0.9270
 Urgen PCI N(%)30(50.85)29(50.00)
 Selective PCI N(%)29(49.15)29(50.00)
Admitting diagnosis0.77(X2)0.8568
 STEMI N(%)13(23.21)12 (21.43)
 NSTEMI N(%)14 (25.00)12 (21.43)
 UAP N(%)20 (35.71)20 (35.71)
 SAP N(%)9 (16.07)12 (21.43)
CRUSADE score-1.18(Z)0.2373
PCI puncture access-(Fisher)1.0000
 Radial artery N(%)41(69.49)40(68.97)
 Femoral artery N(%)18(30.51)18(31.03)
Number of diseased vessel0.37(Z)0.7099
 Single N(%)19(32.20)14(24.14)
 Double N(%)13(22.03)18(31.03)
 Multiple N(%)27(45.76)26(44.83)
Part of diseased vessel
 LM N(%)9(15.25)9(15.52)0.00(X2)0.9686
 AD N(%)49(83.05)45(77.59)0.55(X2)0.4571
 CX N(%)33(55.93)35(60.34)0.23(X2)0.6286
 RC N(%)35(59.32)40(68.97)1.18(X2)0.2769
 Others N(%)12(20.34)5(8.62)3.23(X2)0.0721
Number of stent implantation-0.58(Z)0.5627
IABP implantation17(28.81)16(27.59)0.02(X2)0.8827
Temporary cardiac pacemaker implantation4(6.78)3(5.17)-(Fisher)1.0000

LM: left main coronary; AD: anterior descending artery; CX: circumflex artery; RC: right coronary artery.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.